(267 days)
Not Found
No
The summary does not mention AI, ML, or related terms, and the description focuses on standard signal measurement and display.
No
The device is intended for non-invasively measuring and displaying magnetic signals from the heart, which is a diagnostic function, not a therapeutic one.
Yes
Explanation: The device "measures and displays the magnetic signals produced by the electric currents in the heart," which is a form of diagnostic measurement. While it is described as a "tool," its function is to acquire data about the heart's electrical activity using magnetic signals, which is inherently diagnostic in nature.
No
The device description explicitly lists multiple hardware components including a scan head with sensors, a moveable arm, electronics, a user touch screen, power supply, rechargeable battery, wheeled chassis, and handles. It also utilizes standard ECG electrodes and lead wires.
Based on the provided information, the Creavo Vitalscan Magnetocardiograph is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is to "non-invasively measure and display the magnetic signals produced by the electric currents in the heart." This describes a device that measures physiological signals directly from the patient's body.
- Device Description: The description details a physical device placed adjacent to the patient, using sensors to capture magnetic signals from the heart. It also mentions the use of ECG electrodes for gating, which are applied to the patient's skin.
- Input Imaging Modality: The input is "Magnetic signals produced by the electric currents in the heart," which are physiological signals, not samples taken from the body.
- Anatomical Site: The anatomical site is the "Heart," indicating a direct interaction with the patient's body.
IVD devices, by definition, are used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. The Creavo Vitalscan does not use such specimens. It directly measures a physical phenomenon occurring within the patient's body.
N/A
Intended Use / Indications for Use
The Creavo Vitalscan Magnetocardiograph is intended for use as a tool which non-invasively measures and displays the magnetic signals produced by the electric currents in the heart.
Product codes
DPS
Device Description
The Creavo Vitalscan Magnetocardiograph is a transportable device, when not in use, which includes a scan head containing multiple sensors, a moveable arm, electronics, software, user touch screen, power supply, and a rechargeable battery. The wheeled chassis and handles allow the device to be transportable between patient beds. During use, the device is placed adjacent to the patient bed.
The color touch screen allows the user to enter patient information (e.g., patient name and scan information) and serves as the visual display unit of the numerical and graphical results during testing. The device also incorporates the use of single use standard ECG electrodes and reusable AHA patient lead wires. The ECG electrodes, are used for gating of the magnetocardiograph signal with the patient's cardiac electrical signal and are used to assist triggering the device electronics and software.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Heart
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Creavo Vitalscan Magnetocardiograph has successfully undergone and passed the following standards testing for the device:
- . IEC 60601-1-2:2007: Medical electrical equipment-- Part 1-2: General requirements for basic safety and essential performance – Collateral standard: Electromagnetic compatibility - Requirements and tests
- . IEC 60601-1:2005+A1:2012: Medical electrical equipment-- Part 1: General requirements for basic safety and essential performance.
- IEC 60601-1-6:2010 + A1:2013: Medical electrical equipment Part 1-6 General requirements for safety - Collateral Standard: Usability
- . IEC 62366: 2007+A1: 2014 Medical devices – Application of usability engineering to medical devices.
The overall final testing on the subject device which included electromagnetic compatibility and electrical safety tests, performance tests, software validation and usability data successfully demonstrated that the design specifications were met and does not raise any new concerns that would adversely affect the safety and effectiveness with respect to the predicate device, thus supporting substantial equivalence. The data generated from this testing demonstrates that the Creavo Vitalscan performed as intended and can successfully record a magnetocardiogram in an unshielded hospital environment.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2340 Electrocardiograph.
(a)
Identification. An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.(b)
Classification. Class II (performance standards).
0
October 12, 2017
Creavo Medical Technologies, Ltd. % Sharon Timberlake Consultant Halloran Consulting Group, LLC 266 Summer Street 8th Floor Boston, Massachusetts 02210
Re: K170154
Trade/Device Name: Creavo Vitalscan Magnetocardiograph Regulation Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II Product Code: DPS Dated: September 11, 2017 Received: September 12, 2017
Dear Sharon Timberlake:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);
1
Page 2 - Sharon Timberlake
and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education (DICE) at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely.
Nicole G. Ibrahim -S
for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known)
K170154
Device Name
Creavo Vitalscan Magnetocardiograph
Indications for Use (Describe)
The Creavo Vitalscan Magnetocardiograph is intended for use as a tool which non-invasively measures and displays the magnetic signals produced by the electric currents in the heart.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ☑ Prescription Use (Part 21 CFR 801 Subpart D) | ☐ Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the
time to review instructions, search existing data sources, gather and maintain the data needed and complete
and review the collection of information. Send comments regarding this burden estimate or any other aspect
of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services
Food and Drug Administration
Office of Chief Information Officer
Paperwork Reduction Act (PRA) Staff
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of
information unless it displays a currently valid OMB number."
EF
PSC Publishing Services (301) 443-6740
3
510(k) Summary
This 510(k) summary is being submitted in accordance with 21 CFR 807.92
1. Submitter's Information
- Name: Creavo Medical Technologies Ltd.
- Address: Creavo Medical Technologies, Ltd. 2020 House, Siskin Drive Middlemarch Business Park Coventry, United Kingdom CV3 4FJ
- Contact: Sharon Timberlake, MSHS, RAC, CCRA Halloran Consulting Group, Inc. Phone: (617) 957-1434 Email: stimberlake@hallorancg.com
Date Prepared: September 11, 2017
2. Device Information
| Trade/Propriety Name: | Creavo Vitalscan Magnetocardiograph |
|---|---|
| Common/Usual Name: | Magnetocardiograph |
| Classification Name: | Electrocardiograph (21 CFR 870.2340) |
| Product Code: | DPS |
3. Predicate Device
CardioMag Imaging, Inc. CMI 2409 Magnetocardiograph 510(k) No.: K033488
4. Indications for Use
The Creavo Vitalscan Magnetocardiograph is intended for use as a tool which noninvasively measures and displays the magnetic signals produced by the electric currents in the heart.
4
5. Device Description
The Creavo Vitalscan Magnetocardiograph is a transportable device, when not in use, which includes a scan head containing multiple sensors, a moveable arm, electronics, software, user touch screen, power supply, and a rechargeable battery. The wheeled chassis and handles allow the device to be transportable between patient beds. During use, the device is placed adjacent to the patient bed.
The color touch screen allows the user to enter patient information (e.g., patient name and scan information) and serves as the visual display unit of the numerical and graphical results during testing. The device also incorporates the use of single use standard ECG electrodes and reusable AHA patient lead wires. The ECG electrodes, are used for gating of the magnetocardiograph signal with the patient's cardiac electrical signal and are used to assist triggering the device electronics and software.
6. Performance Data Summary
Creavo Vitalscan Magnetocardiograph has successfully undergone and passed the following standards testing for the device:
- . IEC 60601-1-2:2007: Medical electrical equipment-- Part 1-2: General requirements for basic safety and essential performance – Collateral standard: Electromagnetic compatibility - Requirements and tests
- . IEC 60601-1:2005+A1:2012: Medical electrical equipment-- Part 1: General requirements for basic safety and essential performance.
- IEC 60601-1-6:2010 + A1:2013: Medical electrical equipment Part 1-6 General requirements for safety - Collateral Standard: Usability
- . IEC 62366: 2007+A1: 2014 Medical devices – Application of usability engineering to medical devices.
The overall final testing on the subject device which included electromagnetic compatibility and electrical safety tests, performance tests, software validation and usability data successfully demonstrated that the design specifications were met and does not raise any new concerns that would adversely affect the safety and effectiveness with respect to the predicate device, thus supporting substantial equivalence. The data generated from this testing demonstrates that the Creavo Vitalscan performed as intended and can successfully record a magnetocardiogram in an unshielded hospital environment.
5
Technological Characteristics Comparison 7.
Table 1 compares the similarities and differences between the Creavo Vitalscan Magnetocardiograph and its predicate device. The Creavo Vitalscan Magnetocardiograph is substantially equivalent to its predicate device based on the indications for use, specifications, and function between the devices.
| Table 1: Comparison of Characteristics of Subject Device with Predicate Device |
|---|
| -------------------------------------------------------------------------------- |
| Specification | Creavo Vitalscan
Magnetocardiograph
(subject device) | CMI 2409 Magnetocardiograph
(predicate device) | Similar | Different |
|-------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------|-----------|
| Intended Use | The Creavo Vitalscan
Magnetocardiograph is intended
for use as a tool which non-
invasively measures and displays
the magnetic signals produced by
the electric currents in the heart. | The CMI Magnetocardiograph is
intended for use as tool which
non-invasively measures and
displays the magnetic signals
produced by the electric
currents in the heart. | × | |
| Transportable Device | Yes | No | | X |
| Shielded Room | Not required | Not Required | × | |
| Environmental
Exclusion Criteria | No Exclusion
(Vitalscan is tolerant to ferrous
material and electromagnetic
interference) | Minimum distances specified to
ferrous material (e.g. beds
chairs) and sources of
interference (e.g. fluorescent
light monitors) | | X |
| Patient Bed as Part of
Device | No | Yes
Magnetically inert bed required | | X |
| Electrical
Requirements | 115/230 VAC; 3.0A/6.0A;
50/60Hz | 100/120/230/240 VAC;
2A/1.5A/1.5A/1.0A;
50/60 Hz | X | |
| # of ECG lead(s) | 3 | 3 | X | |
| Type of Signal | Magnetic | Magnetic | × | |
| Magnetic Field
Localization | Yes | Yes | X | |
| Magnetic
Detector/Sensor Type | Yes | Yes | X | |
| # of Magnetic
Detectors/ Sensors | 37 sensor/channel device with
induction coil sensors | 9 sensors that require four
different 90 second scans
(effectively 36 with re-
positioning) | | X |
| Sensor Environment | Induction coil device: Functions at
room temperature.
10-34 °C | SQUID device: Functions in
liquid helium cryogenic system.
-269 °C | | X |
| Cryogen Used | None | Liquid Helium | | X |
6
Statement of Substantial Equivalence 8.
The Creavo Vitalscan Magnetocardiograph described in this submission is substantially equivalent to the predicate device CMI 2409 Magnetocardiograph (K033488) manufactured by CardioMag Imaging, Inc. and does not raise new questions in regards to safety or effectiveness with respect to the design, device characteristics, performance testing and intended use.
| Intentionally left blank | |
|---|---|